Skip to content
Boca Raton City Online – Lifestyle
Author:
OKYO Pharma LTD
OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting
April 7, 2026
OKYO Pharma Announces Chairman and Founder Acquires Shares
March 19, 2026
OKYO Pharma Announces Director Acquires Shares
March 19, 2026
OKYO Pharma Announces Chief Development Officer and Director Acquires Shares
March 19, 2026
OKYO Pharma Reports New Phase 2 Data Demonstrating Meaningful Improvements in Patient-Reported Quality of Life Outcomes with Urcosimod in Neuropathic Corneal Pain
March 18, 2026
OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress
March 7, 2026
OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares
March 6, 2026
OKYO Pharma Announces Public Offering of Ordinary Shares
March 6, 2026
OKYO Pharma Announces Transition of At-The-Market Equity Offering Facility to Leerink Partners
March 6, 2026
OKYO Pharma Strengthens World Class Leadership Team with Appointment of Flavio Mantelli, MD, PhD as Chief Medical Officer
March 5, 2026
←
Previous Page
1
2